A supplement to Pediatric News.
Excerpta Medica designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award.
Supported by an unrestricted educational grant from Braintree Laboratories, Inc.
Highlights of presentations made at an annual meeting held May 17-21, 2003, in Orlando, Florida.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 8.
Contents
Perspectives on Constipation and Encopresis: Current Issues and New Findings
Neil T. Tucker, MD, Private Practice
Pediatric Gastroenterology
San Antonio, Texas Discusses the unlabeled use of polyethylene glycol 3350.
Infant Dyschezia and Constipation in Infants and Toddlers
Warren P. Bishop, MD, Associate Professor of Pediatrics
Director, Division of Gastroenterology
University of Iowa, Iowa City Clinical Grants: Braintree Laboratories, Inc. He discusses the unlabeled use of polyethylene glycol 3350.
Therapies for Constipation and Encopresis in Children
Vera Loening-Baucke, MD, Professor of Pediatrics
University of Iowa, Iowa City Clinical Grants: Braintree Laboratories, Inc.; Consultant: Braintree Laboratories, Inc. She discusses the unlabeled use of polyethylene glycol 3350.
Conventional vs. Newer Therapy for the Treatment of Childhood Constipation
Wieger P. Voskuijl, MD, Research Fellow
Department of Pediatric Gastroenterology, Academic Medical Center
Amsterdam Nothing to disclose.
Safety and Efficacy of Treatment for Chronic Constipation
Dinesh S. Pashankar, MD, MRCP, Clinical Assistant Professor of Pediatrics
Pediatric Gastroenterologist
University of Iowa, Iowa City Clinical Grants: Braintree Laboratories, Inc.; Consultant: Braintree Laboratories, Inc.
Comparison of Two Bowel Preparations Before Colonoscopy
Jack A. DiPalma, MD, Professor of Medicine
Director of Gastroenterology
University of South Alabama College of Medicine, Mobile Clinical Grants: Braintree Laboratories, Inc.; Consultant: Braintree Laboratories, Inc.
Functional Defecation Disorders in Children: Nonretentive Fecal Soiling
Samuel Nurko, MD, Director, Motility Center
Boston Children's Hospital
Target Audience
This activity has been developed for pediatricians and other health care professionals involved in the treatment of constipation in children.
Educational Needs
Constipation is a common complaint in clinical practice. Constipation in pediatric patients often is complicated by behavioral issues, communication difficulties, and parental involvement. Diagnostic criteria vary, and conventional therapies often pose challenges related to patience acceptance and tolerability. Better appreciation of the complicating factors can aid physicians' clinical decision making related to diagnosis, evaluation, and treatment of constipation and encopresis.
Learning Objectives
After reading the material in this educational publication, participants should be able to:
• Appreciate the limitations of current diagnostic criteria for constipation and encopresis, particularly infant dyschezia.
• Recognize the treatment options for childhood constipation.
• Recognize features of functional defecation disorders in children.
• Evaluate the safety and efficacy of polyethylene glycol (PEG) 3350 in comparison to other therapies for constipation.
• Understand the potential of PEG 3350 as an option for bowel cleansing prior to colonoscopy.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Excerpta Medica and Internal Medicine News. Excerpta Medica is accredited by the ACCME to provide continuing medical education for physicians.
Excerpta Medica designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
The American Medical Association has determined that non-U.S. licensed physicians who participate in this activity are eligible for AMA Physician's Recognition Award category 1 credit.
